54
Pedeutour F, Forus A, Coindre JM, Berner JM, Nicolo G, Michiels JF et al.
Structure of the supernumerary ring and giant rod chromosomes in adipose
tissue tumors. Genes Chromosomes Cancer. 1999 Jan;24(1):30-41.
Perry A, Anderl K, Borell TJ, Kimmel DW, Wang CH, O'Fallon JR et al.
Detection of p16, RB, CDK4, and p53 gene deletion and amplification by
fluorescence in situ hybridization in 96 gliomas. Am J Clin Pathol. 1999
Dec;112(6):801-9.
Persson F, Olofsson A, Sjögren H, Chebbo N, Nilsson B, Stenman G et al.
Cancer Lett. 2008 Feb 18;260(1-2):37-47. Characterization of the 12q
amplicons by high-resolution, oligonucleotide array CGH and expression
analyses of a novel liposarcoma cell line. Cancer Lett. 2008 Feb 18;260(1-
2):37-47.
Pilotti S, Della Torre G, Lavarino C, Di Palma S, Sozzi G, Minoletti F et al.
Distinct mdm2/p53 expression patterns in liposarcoma subgroups: implications
for different pathogenetic mechanisms. J Pathol. 1997 Jan;181(1):14-24.
Pilotti S, Della Torre G, Mezzelani A, Tamborini E, Azzarelli A, Sozzi G et al.
The expression of MDM2/CDK4 gene product in the differential diagnosis of
well differentiated liposarcoma and large deep-seated lipoma. Br J Cancer.
2000 Apr;82(7):1271-5.
Ranade K, Hussussian CJ, Sikorski RS, Varmus HE, Goldstein AM, Tucker MA
et al. Mutations associated with familial melanoma impair p16INK4 function. Nat
Genet. 1995 May;10(1):114-6.
Rosai J, Akerman M, Dal Cin P, DeWever I, Fletcher CD, Mandahl N et al.
Combined morphologic and karyotypic study of 59 atypical lipomatous tumors.
Evaluation of their relationship and differential diagnosis with other adipose
tissue tumors (a report of the CHAMP Study Group). Am J Surg Pathol. 1996
Oct;20(10):1182-9.
Robles AI, Rodriguez-Puebla ML, Glick AB, Trempus C, Hansen L, Sicinski P et
al. Reduced skin tumor development in cyclin D1-deficient mice highlights the
oncogenic ras pathway in vivo. Genes Dev. 1998 Aug 15;12(16):2469-74.
Ruas M, Peters G. The p16INK4a/CDKN2A tumor suppressor and its relatives.
Biochim Biophys Acta. 1998 Oct 14;1378(2):F115-77.
Rubin BP, Dal Cin P. The genetics of lipomatous tumors. Semin Diagn Pathol.
2001 Nov;18(4):286-93.
Sabah M, Cummins R, Leader M, Kay E. Immunoreactivity of p53, Mdm2,
p21(WAF1/CIP1) Bcl-2, and Bax in soft tissue sarcomas: correlation with
histologic grade. Appl Immunohistochem Mol Morphol. 2007 Mar;15(1):64-9.
Sandberg AA. Cytogenetics and molecular genetics of bone and soft-tissue
tumors. Am J Med Genet. 2002 Oct;115(3):189-93.
Schmidt H, Bartel F, Kappler M, Wurl P, Lange H, Bache M et al. Gains of 13q
are correlated with a poor prognosis in liposarcoma. Mod Pathol 2005;18:638–
44.